Extab Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Extab General Information
Description
Developer of bio pharmaceutical products for smoking cessation. The company's bio pharmaceutical products include development of drugs for clinical trail purposes and owns the license rights of Tabex which is a medicinal product and is safe and efficient device for smoking cessation, enabling patients to get access to cost effective treatment.
Contact Information
Website
www.extabpharma.comCorporate Office
- Corporation Trust Centre
- 1209 Orange Street
- Wilmington, DE 19801
- United States
Corporate Office
- Corporation Trust Centre
- 1209 Orange Street
- Wilmington, DE 19801
- United States
Extab Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Extab FAQs
-
When was Extab founded?
Extab was founded in 2008.
-
Where is Extab headquartered?
Extab is headquartered in Wilmington, DE.
-
What industry is Extab in?
Extab’s primary industry is Drug Discovery.
-
Is Extab a private or public company?
Extab is a Private company.
-
What is the current valuation of Extab?
The current valuation of Extab is .
-
What is Extab’s current revenue?
The current revenue for Extab is .
-
When was Extab acquired?
Extab was acquired on 14-May-2015.
-
Who acquired Extab?
Extab was acquired by Achieve Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process